These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

91 related items for PubMed ID: 2382234

  • 41. In vivo administration of anti-CD4 monoclonal antibody prolongs survival in longtailed macaques with experimental allergic encephalomyelitis.
    Rose LM, Alvord EC, Hruby S, Jackevicius S, Petersen R, Warner N, Clark EA.
    Clin Immunol Immunopathol; 1987 Dec; 45(3):405-23. PubMed ID: 2445510
    [Abstract] [Full Text] [Related]

  • 42. Prolongation of primate renal allograft survival by anti-Tac, an anti-human IL-2 receptor monoclonal antibody.
    Reed MH, Shapiro ME, Strom TB, Milford EL, Carpenter CB, Weinberg DS, Reimann KA, Letvin NL, Waldmann TA, Kirkman RL.
    Transplantation; 1989 Jan; 47(1):55-9. PubMed ID: 2643232
    [Abstract] [Full Text] [Related]

  • 43. Prolonged survival of baboon renal allografts using idarubicin-conjugated anti-CD4 monoclonal antibodies.
    Botha JF, Tandon V, Linley W, Mall A, Davison G, Shephard E, McKenzie IF, Kahn D.
    Transpl Int; 2000 Jan; 13 Suppl 1():S480-1. PubMed ID: 11112059
    [Abstract] [Full Text] [Related]

  • 44. Anti-Tac-H, a humanized antibody to the interleukin 2 receptor, prolongs primate cardiac allograft survival.
    Brown PS, Parenteau GL, Dirbas FM, Garsia RJ, Goldman CK, Bukowski MA, Junghans RP, Queen C, Hakimi J, Benjamin WR.
    Proc Natl Acad Sci U S A; 1991 Apr 01; 88(7):2663-7. PubMed ID: 2011577
    [Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46. The influence of OKT8F treatment on allograft survival in rhesus monkeys.
    Jonker M, Nooij FJ, van Suylichem P, Neuhaus P, Goldstein G.
    Transplantation; 1986 Apr 01; 41(4):431-5. PubMed ID: 3083541
    [Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48. Effects of in vivo administration of monoclonal antibodies specific for human T cell subpopulations on the immune system in a rhesus monkey model.
    Jonker M, Goldstein G, Balner H.
    Transplantation; 1983 Jun 01; 35(6):521-6. PubMed ID: 6346593
    [Abstract] [Full Text] [Related]

  • 49. Treatment with anti-Ia and antiblast/monocyte monoclonal antibodies can prolong skin allograft survival in nonhuman primates.
    Chatterjee S, Bernoco D, Billing R.
    Hybridoma; 1982 Jun 01; 1(4):369-77. PubMed ID: 6765322
    [Abstract] [Full Text] [Related]

  • 50. OKT4 epitope correlates with renal allograft survival in African Americans.
    Bromberg JS, Self S, Zellers L, Baliga P, Rajagopalan PR.
    Cytometry; 1994 Jun 15; 18(2):93-4. PubMed ID: 7523046
    [Abstract] [Full Text] [Related]

  • 51. Anti-CD4 monoclonal antibody administration in renal transplanted patients.
    Morel P, Vincent C, Cordier G, Panaye G, Carosella E, Revillard JP.
    Clin Immunol Immunopathol; 1990 Sep 15; 56(3):311-22. PubMed ID: 2390809
    [Abstract] [Full Text] [Related]

  • 52. Preclinical development of keliximab, a Primatized anti-CD4 monoclonal antibody, in human CD4 transgenic mice: characterization of the model and safety studies.
    Bugelski PJ, Herzyk DJ, Rehm S, Harmsen AG, Gore EV, Williams DM, Maleeff BE, Badger AM, Truneh A, O'Brien SR, Macia RA, Wier PJ, Morgan DG, Hart TK.
    Hum Exp Toxicol; 2000 Apr 15; 19(4):230-43. PubMed ID: 10918514
    [Abstract] [Full Text] [Related]

  • 53. Will immunogenicity limit the use, efficacy, and future development of therapeutic monoclonal antibodies?
    Kuus-Reichel K, Grauer LS, Karavodin LM, Knott C, Krusemeier M, Kay NE.
    Clin Diagn Lab Immunol; 1994 Jul 15; 1(4):365-72. PubMed ID: 8556470
    [Abstract] [Full Text] [Related]

  • 54. The clinical use of monoclonal anti-T-cell antibodies.
    Bach JF, Chatenoud L.
    Med Oncol Tumor Pharmacother; 1984 Jul 15; 1(4):269-73. PubMed ID: 6085816
    [Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59. Importance of Hematopoietic Mixed Chimerism for Induction of Renal Allograft Tolerance in Nonhuman Primates.
    Thaiss CC, Oura T, Sasaki H, Dehnadi A, Matsunami M, Rosales IA, Cosimi AB, Kawai T.
    Transplantation; 2019 Apr 15; 103(4):689-697. PubMed ID: 30300283
    [Abstract] [Full Text] [Related]

  • 60. Addition of Anti-CD40 Monoclonal Antibody to Nonmyeloablative Conditioning With Belatacept Abrogated Allograft Tolerance Despite Induction of Mixed Chimerism.
    Oura T, Hotta K, Rosales I, Dehnadi A, Kawai K, Lee H, Benedict Cosimi A, Kawai T.
    Transplantation; 2019 Jan 15; 103(1):168-176. PubMed ID: 30113996
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.